Zurich Cantonal Bank
RVMD icon

Zurich Cantonal Bank’s Revolution Medicines RVMD Stock Holding History

Zurich Cantonal Bank’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-45,517
Closed -$3.63M – 3343
2025
Q4 		$3.63M Buy
+45,517
New +$2.98M 0.01% 715

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Zurich Cantonal Bank's RVMD Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Revolution Medicines (RVMD) stake by 9.2% in Q2 2026, buying an estimated $915K and bringing the position to 74,284 shares worth $13.9M. The position accounts for 0.03% of the portfolio, ranked #418.

Zurich Cantonal Bank first reported a position in RVMD in Q2 2021 and has held it in 20 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Zurich Cantonal Bank held 74,284 shares of Revolution Medicines worth $13.9M as of Q2 2026.
  • Zurich Cantonal Bank bought 6,266 Revolution Medicines shares in Q2 2026, an estimated $915K.
  • Revolution Medicines made up 0.03% of Zurich Cantonal Bank's portfolio in Q2 2026, its #418 holding.
  • Zurich Cantonal Bank first reported a position in Revolution Medicines in Q2 2021 and has held it in 20 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.